GPCRs and Insulin Receptor Signaling in Conversation: Novel Avenues for Drug Discovery.

Type 2 diabetes is a major health issue worldwide with complex metabolic and endocrine abnormalities. Hyperglycemia, defects in insulin secretion and insulin resistance are classic features of type 2 diabetes. Insulin signaling regulates metabolic homeostasis by regulating glucose and lipid turnover in the liver, skeletal muscle and adipose tissue. Major treatment modalities for diabetes include the drugs from the class of sulfonyl urea, Insulin, GLP-1 agonists, SGLT2 inhibitors, DPP-IV inhibitors and Thiazolidinediones. Emerging antidiabetic therapeutics also include classes of drugs targeting GPCRs in the liver, adipose tissue and skeletal muscle. Interestingly, recent research highlights several shared intermediates between insulin and GPCR signaling cascades opening potential novel avenues for diabetic drug discovery.

• Publication year

  2019

• Venue

  Current Topics in Medicinal Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/1568026619666190712211642PMID 31512997
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Free Fatty Acid Receptor 1 (FFAR1) as an Emerging Therapeutic Target for Type 2 Diabetes Mellitus: Recent Progress and Prevailing Challenges

  2018cited by this paper
• G Protein–Coupled Receptors Targeting Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus

  2018cited by this paper
• Mechanisms of Insulin Action and Insulin Resistance.

  2018cited by this paper
• Hepatic &bgr;-arrestin 2 is essential for maintaining euglycemia

  2017cited by this paper
• GPR55 and the regulation of glucose homeostasis.

  2017cited by this paper
• Deletion of the Akt/mTORC1 Repressor REDD1 Prevents Visual Dysfunction in a Rodent Model of Type 1 Diabetes

  2017cited by this paper
• Islet G‐protein coupled receptors: therapeutic potential for diabetes

  2017cited by this paper
• Cross-Talk Between Insulin Signaling and G Protein–Coupled Receptors

  2017cited by this paper
• The role of α1-adrenergic receptors in regulating metabolism: increased glucose tolerance, leptin secretion and lipid oxidation

  2017cited by this paper
• G protein‐coupled receptors not currently in the spotlight: free fatty acid receptor 2 and GPR35

  2017cited by this paper
• GPCR-Mediated Signaling of Metabolites.

  2017cited by this paper
• The acute glucose lowering effect of specific GPR120 activation in mice is mainly driven by glucagon-like peptide 1

  2017cited by this paper
• cAMP assays in GPCR drug discovery.

  2017cited by this paper
• Enriching Islet Phospholipids With Eicosapentaenoic Acid Reduces Prostaglandin E2 Signaling and Enhances Diabetic β-Cell Function

  2017cited by this paper
• Type 2 Diabetes: Demystifying the Global Epidemic

  2017cited by this paper
• G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges.

  2016cited by this paper
• G protein-coupled receptors (GPCRs) That Signal via Protein Kinase A (PKA) Cross-talk at Insulin Receptor Substrate 1 (IRS1) to Activate the phosphatidylinositol 3-kinase (PI3K)/AKT Pathway*

  2016cited by this paper
• Selective novel inverse agonists for human GPR43 augment GLP-1 secretion.

  2016cited by this paper
• The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470).

  2016cited by this paper
• Regulating the effects of GPR21, a novel target for type 2 diabetes

  2016cited by this paper
• Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus

  2016cited by this paper
• G protein-coupled receptors as targets for anti-diabetic therapeutics

  2016cited by this paper
• Thematic Minireview Series: New Directions in G Protein-coupled Receptor Pharmacology*

  2015cited by this paper
• A novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetes.

  2014cited by this paper
• Mechanistic target of rapamycin (mTOR): a point of convergence in the action of insulin/IGF-1 and G protein-coupled receptor agonists in pancreatic cancer cells

  2014cited by this paper
• The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43

  2013cited by this paper
• TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial.

  2012cited by this paper
• G protein-coupled receptor 21 deletion improves insulin sensitivity in diet-induced obese mice.

  2012cited by this paper
• Inhibition of protein phosphatase 2A activity by PI3Kγ regulates β-adrenergic receptor function.

  2011cited by this paper
• Crosstalk between Insulin/Insulin-like Growth Factor-1 Receptors and G Protein-Coupled Receptor Signaling Systems: A Novel Target for the Antidiabetic Drug Metformin in Pancreatic Cancer

  2010cited by this paper
• The Gq/G11-mediated signaling pathway is critical for autocrine potentiation of insulin secretion in mice.

  2010cited by this paper
• GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects.

  2010cited by this paper
• Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease.

  2009cited by this paper
• Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth.

  2009cited by this paper
• Overexpression of GPR40 in Pancreatic β-Cells Augments Glucose-Stimulated Insulin Secretion and Improves Glucose Tolerance in Normal and Diabetic Mice

  2009cited by this paper
• The insulin receptor: a prototype for dimeric, allosteric membrane receptors?

  2008cited by this paper
• Metabolic Endotoxemia Initiates Obesity and Insulin Resistance

  2007cited by this paper
• Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.

  2007cited by this paper
• The twentieth century struggle to decipher insulin signalling

  2006cited by this paper
• Multiple signalling pathways involved in β2‐adrenoceptor‐mediated glucose uptake in rat skeletal muscle cells

  2006cited by this paper
• The pathobiology of diabetic complications: a unifying mechanism.

  2005cited by this paper
• Ligand-dependent autophosphorylation of the insulin receptor is positively regulated by Gi-proteins.

  2004cited by this paper
• Insulin-Induced Akt Activation Is Inhibited by Angiotensin II in the Vasculature Through Protein Kinase C-&agr;

  2003cited by this paper
• Ghrelin Modulates the Downstream Molecules of Insulin Signaling in Hepatoma Cells*

  2002cited by this paper
• Insulin Induces Heterologous Desensitization of G Protein-Coupled Receptor and Insulin-Like Growth Factor I Signaling by Downregulating β-Arrestin-1

  2002cited by this paper
• Characterization of the β‐adrenoceptor subtype involved in mediation of glucose transport in L6 cells

  2002cited by this paper
• Insulin and Insulin-like Growth Factor I Receptors Utilize Different G Protein Signaling Components*

  2001cited by this paper
• The direct effects of catecholamines on hepatic glucose production occur via α1- and β2-receptors in the dog

  2000cited by this paper
• The direct effects of catecholamines on hepatic glucose production occur via alpha(1)- and beta(2)-receptors in the dog.

  2000cited by this paper
• Effects of quinapril and losartan on insulin sensitivity in genetic hypertensive rats with different metabolic abnormalities.

  1999cited by this paper
• Insulin regulation of the Ras activation/inactivation cycle

  1998cited by this paper
• Insulin-induced phosphorylation and activation of phosphodiesterase 3B in rat adipocytes: possible role for protein kinase B but not mitogen-activated protein kinase or p70 S6 kinase.

  1998cited by this paper
• Insulin-Induced Phosphorylation and Activation of Phosphodiesterase 3B in Rat Adipocytes: Possible Role for Protein Kinase B But Not Mitogen-Activated Protein Kinase or p70 S6 Kinase.

  1998cited by this paper
• Inhibition of Insulin Receptor Activation by Insulin-like Growth Factor Binding Proteins*

  1997cited by this paper
• Insulin action impaired by deficiency of the G-protein subunit Giα2

  1996cited by this paper
• Insulin action impaired by deficiency of the G-protein subunit G ialpha2.

  1996cited by this paper
• Control of hepatic gluconeogenesis: role of fatty acid oxidation.

  1989cited by this paper
• Early signals in the mitogenic response.

  1986cited by this paper

• Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment

  2021cites this paper
• YY1-mediated regulation of type 2 diabetes via insulin

  2021cites this paper
• Adipose Tissue in Health and Disease

  2020cites this paper
• EDITORIAL; GPCR Drug Discovery: Emerging Targets, Novel Approaches and Future Trends.

  2019cites this paper